The United States Pharmacopeia (USP) is soliciting comments from beneficiaries, advocacy groups, pharmacy benefit managers, managed care organizations, trade and professional associations, prescription drug plans, healthcare practitioners, providers, prescription drug manufacturers, and other interested parties on the Draft Medicare Model Guidelines (Model Guidelines) developed by USP as set forth under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA).